TNFSF10 and prostate carcinoma: Combination of Tanshinone I and TRAIL showed synergistic cytotoxicity in PC-3, DU145 and M2182 prostate cancer cells compared to Tanshinone I or TRAIL alone, indicating the potential of Tanshinone I as a TRAIL sensitizer.